Key facts
- This page summarizes EcoR1 Capital, LLC's Form 4 filing for Tango Therapeutics, Inc. (TNGX).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Nov 2024, 19:24.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Additional SEC filing notes
Section 16 status
EcoR1 Capital, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
The filers are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Qualified Fund and Mr. Nodelman. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim ownership of such securities except to the extent of their respective pecuniary interests therein.
Footnote F2
Qualified Fund sold 1,406,529 of the shares sold in this transaction.
Footnote F3
After this transaction, Qualified Fund held 11,156,852 shares of Issuer's Common Stock.
Footnote F4
Qualified Fund sold 58,647 of the shares sold in this transaction.
Footnote F5
After this transaction, Qualified Fund held 11,098,205 shares of Issuer's Common Stock.
Footnote F6
Qualified Fund sold 1,075,794 of the shares sold in this transaction.
Footnote F7
After this transaction, Qualified Fund held 10,022,411 shares of Issuer's Common Stock.